Ryan McQueeney and Maddy Johnson take on this week’s biggest stories, including Gilead’s acquisition of Kite Pharma, the future of the CAR-T therapy industry, and Amazon’s changes to Whole Foods stores. Please pick a time stamped topic below:
(0:35) - Hurricane Harvey and North Korea Tensions
(2:30) - Gilead's Acquisition of Kite Pharma: What Is CAR-T Therapy?
(4:45) - Novartis CAR-T Cell Therapy Receives Approval By FDA
(6:50) - CAR-T Biotech Stocks On The Rise
(10:40) - Is This A New Era For Biotech
(15:15) - Price Cutting On Whole Foods Products
(19:20) - Amazon Echoes and Instacart In-direct Competition
(23:45) - Upcoming Rewards Program For Prime Members
(26:00) - Episode Roundup: Podcast@Zacks.com
Make sure to subscribe and leave the show a rating on iTunes!